Dr. Tien I Karleen Su, MD

Dr. Su practices at Amicus Arthritis and Osteoporosis Center, Inc in Whittier, California.

Dr. Su's NPI, 1750581930, was assigned on July 25, 2007. Dr. Su graduated from David Geffen School of Medicine at UCLA in 2005. Dr. Su holds California license A98890.

Dr. Su's primary practice is Amicus Arthritis and Osteoporosis Center, Inc, at 12456 E Washington Blvd, Whittier, CA 90602 in Los Angeles County. The practice phone is (562) 758-6600.

Dr. Su's primary practice is Amicus Arthritis and Osteoporosis Center, Inc in Whittier, California. Dr. Su is also affiliated with PIH Health Whittier Hospital. The medical group on file is Amicus Arthritis & Osteoporosis Center. Dmand AI also links Dr. Su to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Su practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Su's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Su is board certified in rheumatology by the American Board of Internal Medicine. Dr. Su is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint cyst, joint pain and lupus among the conditions Dr. Su treats.

CMS data shows 17,890 Medicare services from Dr. Su across 16 procedure codes in 2024, for 169 Medicare patients. Medicare paid $294,336 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Su in 2024. The largest group is 75 to 84, with 69 patients. 75% of them have arthritis, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Su's median patient age at 74, with 87% women.

In 2024, Dr. Su wrote 1,125 Medicare Part D claims for 329 patients. 86% of them were for generic drugs. CMS names the drug for 887 of them, across 26 drugs with 11 or more claims each, at $129,866 in total drug cost. In 2023, CMS named 1,648 claims across 34 drugs.

Dr. Su accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Su as offering telehealth.

Dmand AI links Dr. Su to 9 clinical trials, 6 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Lupus Erythematosus, Systemic. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Su that name 3 trials.

CMS Open Payments shows 480 general payments to Dr. Su from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Abbvie Inc. paid the most, $9,001. It also lists 6 research payments totaling $130,019 from 2019 to 2024, naming 3 clinical trials.

Dmand AI lists 1 award for Dr. Su, most recently CMS Stage 1 EHR in 2013.

Dr. Su graduated from David Geffen School of Medicine at UCLA in 2005.

Dr. Su is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.